Projected environmental and public health benefits of extended-interval dosing: an analysis of pembrolizumab use in a US national health system

Alex K Bryant; Jacqueline R Lewy; Danny Bressler; Zoey Chopra; Derek J Gyori; Brian G Bazzell; Julie A Moeller; Sofia I Jacobson; A Mark Fendrick; Eve A Kerr; others

Projected environmental and public health benefits of extended-interval dosing: an analysis of pembrolizumab use in a US national health system

Alex K Bryant
, Jacqueline R Lewy
, Danny Bressler
, Zoey Chopra
, Derek J Gyori
, Brian G Bazzell
, Julie A Moeller
, Sofia I Jacobson
, A Mark Fendrick
, Eve A Kerr
, others

Economics

Research output: Contribution to journal › Article

Original language	English
Pages (from-to)	802--810
Journal	The Lancet. Oncology
Volume	25
Issue number	6
State	Published - 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{5ad9c6e0cef24ad99d60b6449fb333ec,

title = "Projected environmental and public health benefits of extended-interval dosing: an analysis of pembrolizumab use in a US national health system",

author = "Bryant, \{Alex K\} and Lewy, \{Jacqueline R\} and Danny Bressler and Zoey Chopra and Gyori, \{Derek J\} and Bazzell, \{Brian G\} and Moeller, \{Julie A\} and Jacobson, \{Sofia I\} and Fendrick, \{A Mark\} and Kerr, \{Eve A\} and others",

year = "2024",

language = "English",

volume = "25",

pages = "802----810",

journal = "The Lancet. Oncology",

number = "6",

}

TY - JOUR

T1 - Projected environmental and public health benefits of extended-interval dosing: an analysis of pembrolizumab use in a US national health system

AU - Bryant, Alex K

AU - Lewy, Jacqueline R

AU - Bressler, Danny

AU - Chopra, Zoey

AU - Gyori, Derek J

AU - Bazzell, Brian G

AU - Moeller, Julie A

AU - Jacobson, Sofia I

AU - Fendrick, A Mark

AU - Kerr, Eve A

AU - others, null

PY - 2024

Y1 - 2024

M3 - Article

VL - 25

SP - 802

EP - 810

JO - The Lancet. Oncology

JF - The Lancet. Oncology

IS - 6

ER -